IFN-γ expression in CD4+ T cells of SS model mice was significantly enhanced by CCL22, whereas there were no changes in IL-4 and IL-17 expressions (Supplemental Figures 3C,D). This evidence concerns the gene IL17A and synovial sarcoma.